Evelyn Hartman

Evelyn Hartman

Science & Pharma Writer

Evelyn Hartman spent the better part of a decade writing for academic research groups before she realized that the people who most needed to understand this science — patients, families, curious minds — were the last ones reading it. That gap bothered her enough to make a career change. She traded the lab newsletter circuit for independent science journalism, and hasn't looked back.

At Longevity Direct, Evelyn covers the frontier where cellular biology meets clinical practice: rapamycin protocols, metformin's emerging non-diabetic applications, GLP-1 receptor agonists, epigenetic clocks, and the hormonal shifts that quietly reshape health after midlife. She brings the same rigour she learned writing for scientists, but with the conviction that complex ideas deserve clear, honest prose — not jargon designed to impress rather than inform.

When she's not deep in a clinical trial preprint, Evelyn is somewhere on a trail, most likely planning what she'll cook when she gets back. Her Ottolenghi cookbook is heavily annotated.

72Articles Written
7Topics
September 2025Member since

Areas of Expertise

Aging ScienceCellular BiologyPharmaceuticals & Longevity DrugsClinical TrialsEpigeneticsHormones & EndocrinologyNeuroplasticity

Evelyn Hartman's Articles